z-logo
open-access-imgOpen Access
IgG‐mediated anaphylaxis via Fcγ receptor in CD40‐deficient mice
Author(s) -
Hisashi Wakayama,
Yoshinori Hasegawa,
Tsutomu Kawabe,
Hidehiko Saito,
Hitoshi Kikutani,
Kaoru Shimokata
Publication year - 1998
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1046/j.1365-2249.1998.00717.x
Subject(s) - anaphylaxis , immunology , immunoglobulin e , medicine , ovalbumin , antigen , antibody , allergy
Anaphylaxis denotes an immediate hypersensitivity reaction to allergen, exclusively mediated by IgE antibodies. However, IgE antibodies do not explain all the syndromes that are encountered. We investigated potent IgG‐mediated anaphylaxis in CD40‐deficient mice that lack the immunoglobulin class switching for T cell‐dependent antigens. Immunization with ovalbumin did not induce either humoral responses of IgG, IgA, and IgE, or systemic anaphylaxis in CD40‐deficient mice. Although systemic anaphylaxis by active immunization was not observed in CD40‐deficient mice, both passive cutaneous anaphylaxis (PCA) and passive systemic anaphylaxis assessed by mouse blood pressure monitoring with cervical artery catheterization did take place when antigen‐specific IgG was transferred and then antigen challenge given. Further, to investigate the inflammatory pathway of IgG‐mediated immediate hypersensitivity reactions, we focused on the Fcγ receptor (FcγR) function. Pretreatment of the mice with the anti‐FcγRII/FcγRIII MoAb clearly blocked the response of PCA and passive systemic anaphylaxis, suggesting that they were initiated through FcγR. In conclusion, we directly demonstrate the IgG‐mediated anaphylaxis and its triggering mechanism through FcγR in in vivo conditions. In addition to IgE‐mediated anaphylaxis, IgG‐mediated anaphylaxis should be considered and the blocking of FcγR would provide one of the therapeutic targets for the control of IgG‐mediated hypersensitivity diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here